Skip to content
10-Q

Quarterly Report

LEMAITRE VASCULAR INC LMAT

0001437749-25-015479

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 22.59M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $25.34M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $25.61M
Current Liabilities Q1 2025 · Mar 31, 2025 $24.75M
Current Liabilities Q1 2025 · Dec 31, 2024 $30.61M
Total Liabilities Q1 2025 · Mar 31, 2025 $208.43M
Total Liabilities Q1 2025 · Dec 31, 2024 $214.53M
Current Assets Q1 2025 · Mar 31, 2025 $408.11M
Current Assets Q1 2025 · Dec 31, 2024 $402.19M
Total Assets Q1 2025 · Mar 31, 2025 $556.01M
Total Assets Q1 2025 · Dec 31, 2024 $551.82M
Shares Diluted Q1 2025 · Mar 31, 2024 22.57M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $358K
Dividends Paid Q1 2025 · Mar 31, 2024 $3.59M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $5.07M
Stockholders Equity Q1 2025 · Mar 31, 2024 $308.5M
Stockholders Equity Q1 2025 · Dec 31, 2023 $297.9M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.44
Eps Basic Q1 2025 · Mar 31, 2024 $0.44
Sga Expense Q1 2025 · Mar 31, 2024 $9.01M
Rd Expense Q1 2025 · Mar 31, 2024 $4.09M
Net Income Q1 2025 · Mar 31, 2024 $9.89M
Operating Income Q1 2025 · Mar 31, 2024 $11.87M
Gross Profit Q1 2025 · Mar 31, 2024 $36.67M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $16.81M